In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

AstraZeneca grants Seroquel rights to Luye Pharma

Executive Summary

AstraZeneca PLC granted Luye Pharma Group Ltd. rights to sell its schizophrenia and bipolar disease treatment Seroquel/Seroquel XR (quetiapine) in the UK, China, Brazil, Australia, Saudia Arabia, Mexico, South Korea, Thailand, Argentina, Malaysia, South Africa, and a number of other international countries.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register